(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
3 days till quarter result
(bmo 2024-05-01)
Expected move: +/- 7.63%
@ $43.42
Utstedt: 8 apr 2024 @ 15:30
Avkastning: -4.20%
Forrige signal: apr 4 - 18:17
Forrige signal:
Avkastning: 0.06 %
Live Chart Being Loaded With Signals
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy...
Stats | |
---|---|
Dagens volum | 540 395 |
Gjennomsnittsvolum | 1.07M |
Markedsverdi | 6.06B |
EPS | $0 ( 2024-02-21 ) |
Neste inntjeningsdato | ( $-1.070 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -16.25 |
ATR14 | $0.0240 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-15 | Baroldi Joseph | Sell | 10 838 | Restricted Stock Unit |
2024-04-15 | Baroldi Joseph | Buy | 10 838 | Common Stock |
2024-04-16 | Baroldi Joseph | Sell | 4 006 | Common Stock |
2024-04-15 | Birchler Brian | Buy | 1 875 | Common Stock |
2024-04-16 | Birchler Brian | Sell | 905 | Common Stock |
INSIDER POWER |
---|
45.60 |
Last 100 transactions |
Buy: 1 051 999 | Sell: 391 277 |
Volum Korrelasjon
Ionis Pharmaceuticals Inc Korrelasjon
10 Mest positive korrelasjoner | |
---|---|
ALVR | 0.928 |
BGFV | 0.913 |
GRNA | 0.902 |
INFI | 0.897 |
CARE | 0.895 |
CMCT | 0.893 |
GBCI | 0.889 |
EQ | 0.889 |
BIOC | 0.885 |
CRBU | 0.882 |
10 Mest negative korrelasjoner | |
---|---|
STAY | -0.908 |
TRMD | -0.878 |
BCOR | -0.875 |
PAYA | -0.873 |
IBEX | -0.868 |
PDFS | -0.867 |
BNIXU | -0.866 |
TGLS | -0.865 |
LRFC | -0.865 |
ARDX | -0.861 |
Visste du det?
Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).
Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.
Ionis Pharmaceuticals Inc Korrelasjon - Valuta/Råvare
Ionis Pharmaceuticals Inc Økonomi
Annual | 2023 |
Omsetning: | $787.65M |
Bruttogevinst: | $778.51M (98.84 %) |
EPS: | $-2.56 |
FY | 2023 |
Omsetning: | $787.65M |
Bruttogevinst: | $778.51M (98.84 %) |
EPS: | $-2.56 |
FY | 2022 |
Omsetning: | $587.00M |
Bruttogevinst: | $573.00M (97.61 %) |
EPS: | $-1.900 |
FY | 2021 |
Omsetning: | $810.46M |
Bruttogevinst: | $799.61M (98.66 %) |
EPS: | $-0.200 |
Financial Reports:
No articles found.
Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of TTR amyloidosis; Olezarsen for patients with severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Tofersen to inhibit the production of superoxide dismutase 1. In addition, the company develops medicines for metabolic diseases, infectious diseases, renal diseases, ophthalmic diseases, and cancer. It has a strategic collaboration with Biogen Inc.; and collaboration and license agreement with AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis AG, Roche, Janssen Biotech, Inc., and Flamingo Therapeutics, Inc. Ionis Pharmaceuticals, Inc. was founded in 1989 and is based in Carlsbad, California.
Om Live Signaler
Live Trading signaler pa denne siden er ment til å hjelpe deg i beslutningsprossessen for når du bør KJØPE eller SELGE NA. Signalene har opp mot 1-minutt forsinkelse; som med alle andre indikatorer og signaler, er det en viss sjanse for feil eller feilkalkuleringer.
Live signalene er kun veiledende, og getagraph.com tar ikke noen form for ansvar basert pa handlinger gjort på disse signalene som beskrevet i Terms of Use. Signalene er basert på en rekke indikatorer og påliteligheten vil variere sterke fra aksje til aksje.